These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 24641308

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Entering new areas in known fields: recombinant fusion protein linking recombinant factor VIIa with recombinant albumin (rVIIa-FP) - advancing the journey.
    Négrier C.
    Thromb Res; 2016 May; 141 Suppl 3():S9-S12. PubMed ID: 27288065
    [Abstract] [Full Text] [Related]

  • 5. Recombinant fusion protein linking factor VIIa with albumin (rVIIa-FP): Tissue distribution in rats.
    Herzog E, Harris S, McEwen A, Henson C, Pragst I, Dickneite G, Schulte S, Zollner S.
    Thromb Res; 2014 Aug; 134(2):495-502. PubMed ID: 24958222
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prolonged in-vivo half-life of factor VIIa by fusion to albumin.
    Weimer T, Wormsbächer W, Kronthaler U, Lang W, Liebing U, Schulte S.
    Thromb Haemost; 2008 Apr; 99(4):659-67. PubMed ID: 18392323
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Administration of recombinant FVIIa (rFVIIa) to concizumab-dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbits.
    Lauritzen B, Olling J, Abel KL, Augustsson C, Balling K, Bjelke M, Hegelund AC, Hilden I.
    J Thromb Haemost; 2019 Mar; 17(3):460-469. PubMed ID: 30614620
    [Abstract] [Full Text] [Related]

  • 12. Enhanced Pharmacokinetics of Factor VIIa as a Monomeric Fc Fusion.
    Salas J, Liu T, Lu Q, Kulman JD, Ashworth T, Kistanova E, Moore N, Pierce GF, Jiang H, Peters R.
    Thromb Res; 2015 May; 135(5):970-6. PubMed ID: 25721936
    [Abstract] [Full Text] [Related]

  • 13. Pioneering designs for recombinant coagulation factors.
    Schulte S.
    Thromb Res; 2011 May; 128 Suppl 1():S9-12. PubMed ID: 22221848
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improved kinetics of rIX-FP, a recombinant fusion protein linking factor IX with albumin, in cynomolgus monkeys and hemophilia B dogs.
    Nolte MW, Nichols TC, Mueller-Cohrs J, Merricks EP, Pragst I, Zollner S, Dickneite G.
    J Thromb Haemost; 2012 Aug; 10(8):1591-9. PubMed ID: 22726310
    [Abstract] [Full Text] [Related]

  • 18. Recombinant factor VIIa does not induce hypercoagulability in vitro.
    Gallistl S, Cvirn G, Muntean W.
    Thromb Haemost; 1999 Feb; 81(2):245-9. PubMed ID: 10064000
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium.
    Mauser-Bunschoten EP, de Goede-Bolder A, Wielenga JJ, Levi M, Peerlinck K.
    Neth J Med; 1998 Dec; 53(6):249-55. PubMed ID: 9883002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.